TABLE 2.
Characteristic | No. (%) of patients with:
|
Pf | ||
---|---|---|---|---|
Ampicillin-resistant enterococci | HLGRa enterococci | Aminoglycoside- and ampicillin-susceptible enterococcib | ||
Total patients | 9c | 10d | 68e | |
Male/female | 3/6 | 4/6 | 33/35 | NS |
Prior hospitalization | 8 (89) | 9 (90) | 15 (22) | <0.001 |
Prior surgery | 1 (11) | 2 (20) | 5 (7) | NS |
Prior antibiotics | 6 (67) | 3 (30) | 24 (36) | 0.03 |
Underlying diseases | 7 (78) | 10 (100) | 60 (89) | NS |
Fast food >3×/week | 0 (0) | 0 (0) | 3 (4) | NS |
Dental procedure | 1 (11) | 2 (20) | 21 (31) | NS |
Prior nursing home | 0 (0) | 1 (10) | 1 (2) | NS |
Travel | 2 (22) | 2 (20) | 29 (42) | NS |
HLGR, high-level-gentamicin-resistant.
Gentamicin and streptomycin MIC, <2,000 μg/ml; ampicillin MIC, <16 μg/ml.
Includes six E. faecium, two E. faecalis, and one E. gallinarum isolates.
All E. faecalis isolates.
Includes 48 E. faecalis isolates and 20 E. faecium isolates.
All variables were not significant (NS) in multivariate analysis.